Can an AI voice coach ease depression? new study tests lumen
NCT ID NCT05603923
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether an AI voice coach called Lumen can help adults with mild-to-moderate depression or anxiety. 200 participants were randomly assigned to receive problem-solving training from Lumen, a human coach, or a waitlist. The goal was to see if the AI coach could improve emotional well-being by teaching practical skills to tackle daily problems.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Lumen voice-based AI coach delivering Problem-Solving Treatment (PST)
- What this could lead to
- If it works, this could offer a convenient, accessible way to help people manage depression and anxiety symptoms without medication or in-person therapy.
- What could go wrong
- This is a small, early-phase study (200 people) comparing AI coaching to human coaching and a waitlist. Results may not apply to everyone, and the AI may not be as effective as human therapists.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
200 people
The number who actually took part.
- Started
-
Jan 2023
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age: ≥ 18 years * Emotional distress defined by elevated depressive (PHQ-9 scores 10-19) and/or anxious symptoms (GAD-7 scores 10-14) * Willing and able to provide informed eConsent and HIPAA authorization Exclusion Criteria: * Unable to speak, read, or understand English for informed consent * Current pharmacotherapy or psychotherapy (individual or professionally led group therapy) for depression or anxiety (note: participants are not withdrawn post-randomization if they begin pharmacotherapy drugs or start psychotherapy during the study.) * Suicidal ideation per PHQ-9 with active plan * Bipolar or psychotic disorder, or current psychiatric treatment * Weight ≥325 pounds due to brain scanner constraints, MRI contraindications, traumatic brain injuries, and tumor or any other known structural abnormality in the brain * Severe medical condition (e.g., myocardial infarction or stroke or new cancer diagnosis in the past 6 months, end-stage organ failure, terminal illness) or residence in a long-term care facility * Diagnosis of cancer (other than non-melanoma skin cancer) that is/was active or treated with radiation or chemotherapy within the past year * Active alcohol or substance use disorder (including prescription drugs) based on the CAGE Questionnaire Adapted to Include Drugs (CAGE-AID) * Cognitive impairment based on the Callahan 6-item screener * Current or planned pregnancy or lactating (\<6 months postpartum) * Participation in other investigational treatment studies that would significantly affect participation in this study, raise safety concerns, and/or confound outcomes (participant may be asked to provide the informed consent of the other study for final decision on exclusion by a study psychiatrist) * Family/household member of an already enrolled participant or of a study team member * Plan to move out of the Chicago area during the study period * Does not have reliable Wi-Fi Internet at home * Unwillingness to user personal mobile device to receive study text messages * Investigator discretion for clinical safety or protocol adherence reasons
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Medicine, Vitoux Program on Aging and Prevention
Chicago, Illinois, 60608, United States
-
UIMC Advanced Imaging Center
Chicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Can a phone app that blocks distracting apps ease depression?
- Can video games calm anxious teens?
- Can teachers and a phone app ease teen depression?
- Can imagining exercise boost brain power after spinal cord injury?
- Can a group program teach teens to cope before therapy starts?